Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits

Experimental Neurology

Volumn 141, Issue 1, 1996, Pages 40-46

  Bowes, Mark P ^a   Zivin, Justin A ^a   Thomas, G Roger ^b   Thibodeaux, Harold ^b   Fagan, Susan C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STROKE;

EID: 0030249686     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0137     Document Type: Article

References (48)

1. 1. AUSTIN, S. M., M. CARO, AND D. GEMMEL. 1992. Community hospital experience with recombinant tissue plasminogen activator in acute myocardial infarction. J. Gen. Intern. Med. 7: 197-190.
2. 2. BARONE, F. C., W. J. PRICE, R. F. WHITE, R. N. WILLETTE, AND G. Z. FEUERSTEIN. 1992. Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci. Biobehav. Rev. 16: 219-233.
3. 3. BOWES, M. P., J. A. ZIVIN, AND R. ROTHLEIN. 1993. Monoclonal antibody to the ICAM-I adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119: 215-219.
4. 4. BRITTON, M., A. CARLSSON, AND U. DE FAIRE. 1986. Blood pressure course in patients with acute stroke and matched controls. Stroke 17: 861-864.
5. 5. BROTT, T., E. C. HALEY, D. E. LEVY, W. G. BARSAN, R. L. REED, C. P. OLINGER, AND J. R. MARLER. 1988. Very early therapy for cerebral infarction with tissue plasminogen activator (tPA). Stroke 19: 8.
6. 6. BROTT, T. G., E. C. HALEY, JR., D. E. LEVY, W. BARSAN, J. BRODERICK, G. L. SHEPPARD, J. SPILKER, G. L. KONGABLE, S. MASSEY, R. REED, AND J. R. MARLER. 1992. Urgent therapy for stroke. 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23: 632-640.
7. 7. CALIFF, R. M., D. F. FORTIN, A. N. TENAGLIA, AND D. C. SANE. 1992. Clinical risks of thrombolytic therapy. Am. J. Cardiol. 69: 12A-20A.
8. 8. CARTER, L. P., A. N. GUTHKELCH, J. OROZCO, AND O. TEMELTAS. 1992. Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model. Stroke 23: 883-888.
9. 9. CLARK, W. M., K. P. MADDEN, P. D. LYDEN, AND J. A. ZIVIN. 1991. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits. Stroke 22: 872-876.
10. 10. COLE, D. J., J. C. DRUMMOND, T. S. RUTA, AND N. H. PECKHAM. 1990. Hemodilution and hypertension effects on cerebral hemorrhage in cerebral ischemia in rats. Stroke 21: 1333-1339.
11. 11. DANDAPANI, B. K., S. SUZUKI, R. E. KELLEY, Y. REYES-INGLESIAS, AND R. C. DUNCAN. 1995. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26: 21-24.
12. 12. DEL ZOPPO, G. J. 1990. Relevance of focal cerebral ischemia models. Experience with fibrinolytic agents. Stroke 21: IV-155-IV-160.
13. 13. DEL ZOPPO, G. J., B. R. COPELAND, K. ANDERCHEK, W. HACKE, AND J. A. KOZIOL. 1990. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke 21: 596-601.
14. 14. DEL ZOPPO, G. J., K. POECK, M. S. PESSIN, S. M. WOLPERT, A. J. FURLAN, A. FERBERT, M. J. ALBERTS, J. A. ZIVIN, L. WECHSLER, O. BUSSE, R. GREENLEE, JR., L. BRASS, J. P. MOHR, E. FELDMANN, W. HACKE, C. S. KASE, J. BILLER, D. GRESS, AND S. M. OTIS. 1992. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann. Neurol. 32: 78-86.
15. 15. DEL ZOPPO, G. J., AND THE RT-PA ACUTE STROKE STUDY GROUP. 1990. An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. Stroke 21: IV-174-IV-175.
16. 16. FARIS, A. A., C. A. HARDIN, AND C. M. POSER. 1963. Pathogenesis of hemorrhagic infarction of the brain. Arch. Neurol. 9: 468-472.
17. 17. GLOBUS, J. H., AND J. A. EPSTEIN. 1953. Massive cerebral hemorrhage: Spontaneous and experimentally induced. J. Neuropathol. Exp. Neurol. 12: 107-131.
18. 18. HACKE, W., M. KASTE, C. FIESCHI, D. TONI, E. LESAFFRE, R. VON KUMMER, G. BOYSEN, E. BLUHMKI, G. HÖXTER, M. MAHAGNE, M. HENNERICI, AND ECASS STUDY GROUP. 1995. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 274: 1017-1025.
19. 19. HALEY, E. C., JR., T. G. BROTT, G. L. SHEPPARD, W. BARSAN, J. BRODERICK, J. R. MARLER, G. L. KONGABLE, J. SPILKER, S. MASSEY, C. A. HANSEN, AND J. C. TORNER. 1993. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 24: 1000-1004.
20. 20. HALEY, E. C., JR., D. E. LEVY, T. G. BROTT, G. L. SHEPPARD, M. C. WONG, G. L. KONGABLE, J. C. TURNER, AND J. R. MARLER. 1992. Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 23: 641-645.
21. 21. HART, R. G., AND J. D. EASTON. 1986. Hemorrhagic infarcts. Stroke 17: 586-589.
22. 22. HOLMES, D. R., R. M. CALIFF, AND E. J. TOPOL. 1995. Lessons we have learned from the GUSTO trial. J. Am. Coll. Cardiol. 25: 10S-17S.
23. 23. KASE, C. S., A. M. O'NEAL, M. FISHER, G. N. GIRGIS, AND J. I. ORDIA. 1990. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann. Intern. Med. 112: 17-21.
24. 24. KASE, C. S., M. S. PESSIN, J. A. ZIVIN, G. J. DEL ZOPPO, A. J. FURLAN, J. W. BUCKLEY, AND J. K. LITTLEJOHN. 1992. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Am. J. Med. 92: 384-390.
25. 25. LAURENT, J. P., G. F. MOLINARI, AND J. C. OAKLEY. 1976. Primate model of cerebral hematoma. J. Neuropathol. Exp. Neurol. 35: 560-568.
26. 26. LEE, J. G., A. G. HUDETZ, J. J. SMITH, C. J. HILLARD, Z. J. BOSNJAK, AND J. P. KAMPINE. 1994. The effect of halothane and isoflurane on cerebrocortical microcirculation and autoregulation as assessed by laser-doppler flowmetry. Anesth. Analg. 79: 58-65.
27. 27. LYDEN, P. D., K. P. MADDEN, W. A. CLARK, K. C. SASSE, AND J. A. ZIVIN. 1990. Comparison of cerebral hemorrhage rates following tissue plasminogen activator or streptokinase treatment for embolic stroke in rabbits. Stroke 21: 981-983.
28. 28. LYDEN, P. D., K. P. MADDEN, W. M. CLARK, K. C. SASSE, AND J. A. ZIVIN. 1990. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits. Stroke 21: 1589-1593.
29. 29. LYDEN, P. D., AND J. A. ZIVIN. 1993. Hemorrhagic transformation after cerebral ischemia: Mechanisms and incidence. Cerebrovasc. Brain Met. Rev. 5: 1-16.
30. 30. LYDEN, P. D., J. A. ZIVIN, W. A. CLARK, K. P. MADDEN, K. C. SASSE, V. A. MAZZARELLA, R. D. TERRY, AND G. A. PRESS. 1989. Tissue plasminogen activator mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology 39: 703-708.
31. 31. LYDEN, P. D., J. A. ZIVIN, M. SOLL, M. SITZER, J. F. ROTHROCK, AND J. ALKSNE. 1987. Intracerebral hemorrhage after experimental embolic infarction: Anticoagulation. Arch. Neurol. 44: 848-850.
32. 32. MAGGIONI, A. P., M. G. FRANZOSI, E. SANTORO, H. WHITE, F. VAN DE WERF, AND G. TOGNONI. 1992. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N. Engl. J. Med. 327: 1-6.
33. 33. MORI, E., Y. YONEDA, M. TABUCHI, T. YOSHIDA, S. OHKAWA, Y OHSUMI, K. KITANO, A. TSUTSUMI, AND A. YAMADORI. 1992. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976-982.
34. 34. OVERGAARD, K., T. SEREGHY, G. BOYSEN, H. PEDERSEN, AND N. H. DIEMER. 1992. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model. Stroke 23: 1167-1174.
35. 35. PATEL, P. M., J. C. DRUMMOND, AND D. J. COLE. 1991. Induced hypertension during resoration of flow after temporary middle cerebral artery occlusion in the rat: Effect on neuronal injury and edema. Surg Neurol 36: 195-201.
36. 36. PEREZ-TREPICHIO, A. D., J. L. WILLIAMS, C. H. BLOCK, AND S. C. JONES. 1993. Cardiovascular changes during focal cerebral ischemia in rats. Stroke 24: 691-696.
37. 37. POWERS, W. J. 1993. Acute hypertension after stroke: The scientific basis for treatment decisions. Neurology 43: 461-467.
38. 38. SAKU, Y., J. CHOKI, R. WAKI, J. MASUDA, K. TAMAKI, M. FUJISHIMA, AND J. OGATA. 1990. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke 21: 589-595.
39. 39. SPENCE, J. D., AND R. F. DEL MAESTRO. 1985. Hypertension in Acute Ischemic Strokes. Arch. Neurol 42: 1000-1002.
40. 40. STERZ, F., Y. LEONOV, P. SAFAR, A. RADOVSKY, S. A. TISHERMAN, AND K. OKU. 1990. Hypertension with or without hemodilution after cardiac arrest in dogs. Stroke 21: 1178-1184.
41. 41. THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RT-PA STROKE STUDY GROUP. 1995. Tissue Plasminogen Activator For Acute Ischemic Stroke. N. Engl. J. Med. 333: 1581-1587.
42. 42. THE tPA-AcuTE STROKE STUDY GROUP. 1988. An open multicenter study of the safety and efficacy of various doses of r-tPA in patients with acute stroke: Preliminary results. Stroke 19: 22.
43. 43. WALLACE, J. D., AND L. L. LEVY. 1981. Blood Pressure After Stroke. JAMA 246: 2177-2180.
44. 44. WAUD, D. R. 1972. On biological assays involving quantal responses. J. Pharmacol Exp. Ther. 183: 577-607.
45. 45. ZIVIN, J. A., M. FISHER, U. DEGIROLAMI, C. C. HEMENWAY, AND J. A. STASHAK. 1985. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230: 1289-1292.
46. 46. ZIVIN, J. A., P. D. LYDEN, U. DEGIROLAMI, A. KOCHHAR, V. MAZZARELLA, C. C. HEMENWAY, AND P. JOHNSTON. 1988. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch. Neurol. 45: 387-391.
47. 47. ZIVIN, J. A., AND V. MAZZARELLA. 1991. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch. Neurol. 48: 1235-1238.
48. 48. ZIVIN, J. A., AND D. R. WAUD. 1992. Quantal bioassay and stroke. Stroke 23: 767-773.